Showing 1 - 6 results of 6 for search 'David L. Kolin', query time: 0.03s Refine Results
  1. 1
    Uterine carcinosarcoma associated with a germline nibrin (NBN) mutation

    Uterine carcinosarcoma associated with a germline nibrin (NBN) mutation by Tahireh Markert, David L. Kolin, Panagiotis A. Konstantinopoulos

    Published 2022-04-01
    Get full text
    Article
  2. 2
    Case report: Response to everolimus in a patient with platinum resistant, high grade serous ovarian carcinoma with biallelic TSC2 inactivation

    Case report: Response to everolimus in a patient with platinum resistant, high grade serous ovarian carcinoma with biallelic TSC2 inactivation by Mariko Peterson, David L. Kolin, Panagiotis A. Konstantinopoulos

    Published 2024-03-01
    Get full text
    Article
  3. 3
    Durable remission in a patient with ERBB2-amplified recurrent mucinous ovarian carcinoma treated with Trastuzumab-Carboplatin-Paclitaxel

    Durable remission in a patient with ERBB2-amplified recurrent mucinous ovarian carcinoma treated with Trastuzumab-Carboplatin-Paclitaxel by Alexander J. Neil, Michael G. Muto, David L. Kolin, Panagiotis A. Konstantinopoulos

    Published 2023-08-01
    Get full text
    Article
  4. 4
    Inaugurating High‐Throughput Profiling of Extracellular Vesicles for Earlier Ovarian Cancer Detection

    Inaugurating High‐Throughput Profiling of Extracellular Vesicles for Earlier Ovarian Cancer Detection by Ala Jo, Allen Green, Jamie E. Medina, Sonia Iyer, Anders W. Ohman, Eric T. McCarthy, Ferenc Reinhardt, Thomas Gerton, Daniel Demehin, Ranjan Mishra, David L. Kolin, Hui Zheng, Jinwoo Cheon, Christopher P. Crum, Robert A. Weinberg, Bo R. Rueda, Cesar M. Castro, Daniela M. Dinulescu, Hakho Lee

    Published 2023-09-01
    Get full text
    Article
  5. 5
    A Replication stress biomarker is associated with response to gemcitabine versus combined gemcitabine and ATR inhibitor therapy in ovarian cancer

    A Replication stress biomarker is associated with response to gemcitabine versus combined gemcitabine and ATR inhibitor therapy in ovarian cancer by Panagiotis A. Konstantinopoulos, Alexandre André B. A. da Costa, Doga Gulhan, Elizabeth K. Lee, Su-Chun Cheng, Andrea E. Wahner Hendrickson, Bose Kochupurakkal, David L. Kolin, Elise C. Kohn, Joyce F. Liu, Elizabeth H. Stover, Jennifer Curtis, Nabihah Tayob, Madeline Polak, Dipanjan Chowdhury, Ursula A. Matulonis, Anniina Färkkilä, Alan D. D’Andrea, Geoffrey I. Shapiro

    Published 2021-09-01
    Get full text
    Article
  6. 6
    Satellite repeat RNA expression in epithelial ovarian cancer associates with a tumor-immunosuppressive phenotype

    Satellite repeat RNA expression in epithelial ovarian cancer associates with a tumor-immunosuppressive phenotype by Rebecca L. Porter, Siyu Sun, Micayla N. Flores, Emily Berzolla, Eunae You, Ildiko E. Phillips, Neelima KC, Niyati Desai, Eric C. Tai, Annamaria Szabolcs, Evan R. Lang, Amaya Pankaj, Michael J. Raabe, Vishal Thapar, Katherine H. Xu, Linda T. Nieman, Daniel C. Rabe, David L. Kolin, Elizabeth H. Stover, David Pepin, Shannon L. Stott, Vikram Deshpande, Joyce F. Liu, Alexander Solovyov, Ursula A. Matulonis, Benjamin D. Greenbaum, David T. Ting

    Published 2022-08-01
    Get full text
    Article

Search Tools: